Showing results (101-110 of 125) with videos related to
Sort By:
Pageof 13
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 4, 2020
Efficacy and predictors of short-term first-generation somatostatin analog presurgical treatment in acromegaly: A hospital-based study of 237 casesMing Shen, Yeping Yang, Wenqiang He, et al.Endocrine Journal|July 20, 2016
The value of an acute octreotide suppression test in predicting short-term efficacy of somatostatin analogues in acromegalyMeng Wang, Ming Shen, Wenqiang He, et al.Cell Reports. Medicine|February 8, 2023
Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNETQilin Zhang, Boyuan Yao, Xin Long, et al.Frontiers in Immunology|June 13, 2025
Key indicators for guiding tocilizumab therapy to prevent orbital decompression surgery in hormone-resistant dysthyroid optic neuropathyWenjun Shu, Mingxu Yan, Lu Gan, et al.Neuroradiology|August 13, 2016
Predictive value of T2 relative signal intensity for response to somatostatin analogs in newly diagnosed acromegalyMing Shen, Qilin Zhang, Wenjuan Liu, et al.International Journal of Endocrinology|June 2, 2018
Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based StudyMing Shen, Meng Wang, Wenqiang He, et al.International Journal of Endocrinology|April 10, 2019
Erratum to "Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study"Ming Shen, Meng Wang, Wenqiang He, et al.Molecular Therapy. Oncology|December 16, 2025
Efficacy and safety of BRAF-MEK inhibitors in treatment of Chinese patients with papillary craniopharyngioma: A retrospective cohort studyRui Han, Xiaorong Yan, Boyuan Yao, et al.Radiology|December 17, 2024
Diagnostic Accuracy and Value of CXCR4-targeted PET/MRI Using 68Ga-Pentixafor for Tumor Localization in Cushing DiseaseYue Wu, Yanfei Wu, Boyuan Yao, et al.Iscience|September 6, 2021
Treatment of acromegaly by rosiglitazone via upregulating 15-PGDH in both pituitary adenoma and liverYichao Zhang, Meng Wang, Chenxing Ji, et al.Pageof 13